The Biotech Industry Must Tell Its Story To The Public

Scientific discovery takes long periods of trial and error. When you uncover enough new rules that work, you have a scientific revolution. Every time a big change like this happens in science, we have a fancy word for it: a new paradigm. Every day we are discovering new rules for biotechnology. Sometimes we explore down a dead end; other times, we uncover a new mystery. This is the nature of scientific discovery; it can't be rushed. Look what happened in the Aesop fable about the tortoise and

Written byDan Eramian
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Dan Eramian Scientific discovery takes long periods of trial and error. When you uncover enough new rules that work, you have a scientific revolution. Every time a big change like this happens in science, we have a fancy word for it: a new paradigm.

Every day we are discovering new rules for biotechnology. Sometimes we explore down a dead end; other times, we uncover a new mystery. This is the nature of scientific discovery; it can't be rushed. Look what happened in the Aesop fable about the tortoise and the hare: The tortoise prevailed because he took a slow and sure approach to running the race. Those of us in the biotechnology industry must take the tortoise's approach to establishing and publicizing our paradigm. We must clearly communicate what we are about. If we stay quiet-or if we over-reach or make boastful claims and don't deliver-we may inadvertently foster superstition, confusion, resistance ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies